Materialise’s 3D printed oxygen mask (video)

Video Player is loading.

Play Video

PlaySkip BackwardSkip Forward

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0.00%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Picture-in-PictureFullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-Transparent

Text Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentTransparent

Caption Area Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDrop shadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

ResetDone

Close Modal Dialog

End of dialog window.

This solution is being brought to hospitals quickly and in full compliance with safety regulations.

Materialise has developed the Materialise NIP Connector, a device to convert standard equipment available in most hospitals, into a mask to facilitate breathing for patients by creating positive pressure in the lungs. These assembled masks allow clinicians to reduce the time patients need access to mechanical ventilators, which helps to reduce the strain on ventilator supplies. A 3D printed connector converts standard equipment already available in most hospitals into a  non-invasive positive end expiratory pressure (PEEP) mask (NIP) that can be connected to the oxygen supply (to facilitate breathing for coronavirus patients).

While 3D printing allows for fast and local manufacturing of medical devices, making it possible to bring solutions to hospitals quickly, it’s critical to comply with regulations to ensure the safety of patients and caregivers. Materialise is now fast-tracking the regulatory registration (in Europe and the U.S.). In parallel, Materialise is supporting a clinical trial to test the clinical impact of its use on COVID 19 patients and expects first results to be available within the next two weeks.

Meanwhile, the 3D printing company is upscaling its production capability to make the solution available broadly and quickly. Materialise NIP Connectors will be manufactured at the company’s ISO 13485 certified facilities in Belgium and Plymouth, Michigan and on-site 3D printing facilities of qualified partners. Materialise is looking for partners to get this solution to as many patients as possible.

Questions or collaboration? Contact FightCovid@Materialise.be